Caladrius Biosciences, Inc. (NASDAQ: LSTA) reported Q1 EPS of ($0.55), $0.19 better than the analyst estimate of ($0.74).

For earnings history and earnings-related data on Caladrius Biosciences, Inc. (LSTA) click here.